Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer

A Single Institution Review of Adjuvant Therapy Outcomes for Resectable Pancreatic Adenocarcinoma: Outcome and Prognostic Indicators

(2010) Richard Kim et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma

(2009) H Akita et al.   ONCOGENE

Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer

(2008) Sandra Pérez-Torras et al.   BIOCHEMICAL PHARMACOLOGY

Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

(2008) James J. Farrell et al.   GASTROENTEROLOGY

Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)

(2008) Michele M. Corsini et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer

(2008) Yuqiu Jiang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS